Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The human host adaptive immune system is a sophisticated subsystem of the overall immune system composed of highly specialized cells and processes that eliminate pathogens or prevent their growth. It is characterized by the ability to recognize and remember specific pathogens, providing long-term immunity through immunological memory (StatPearls, 2023; NIH, 2020). The primary components include B lymphocytes, which produce antibodies, and T lymphocytes, which mediate cellular immunity and regulate the overall response (Wikipedia, 2024). Dysregulation of this system is central to various pathologies, including autoimmune diseases where the system attacks host tissues, and cancers that evade immune detection (PubMed, 2021). Pharmacological intervention typically targets specific components of this system, such as using monoclonal antibodies to neutralize cytokines or checkpoint inhibitors to enhance T-cell activity against tumors (NIH, 2020).
Modulation of lymphocyte activation, antigen presentation, and cytokine signaling to either suppress or stimulate immune activity (StatPearls, 2023).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human host adaptive immune system.